Join the fight against COVID-19
Right now there's a lack of research focusing on children and how the virus and pandemic affects them. There are still many unanswered questions for parents that need tackling, such as:
- Why are some children more vulnerable to COVID-19 than others?
- How is the pandemic affecting my child's mental health?
- How can I protect my child now, and from viruses like this in the future?
We need your help to raise over £1 million to drive forward research to better understand the impact of COVID-19 on children.
Driving research forward
Building on our impressive track record of supporting high quality research that saves and changes children’s lives, we are now funding five new research projects to help tackle COVID-19 in children.
Tackling COVID-19 with your support
Find out more about the five new research projects we’re supporting to help tackle COVID-19 in children.
Vaccine development
Former Action Research Training Fellow Professor Andrew Pollard helped develop and test the Oxford/AstraZeneca vaccine.
Expert advisory group
Meet our expert advisory group who are helping guide how we can best fund research in this important area.
Sophia’s story
Sophia’s not enjoying lockdown one bit. Born with a rare disease, Sophia is at much greater risk from COVID-19 than most children. Medical research is essential to protect vulnerable children like her.
There are still many unanswered questions about why COVID-19 affects some children more severely than others and how we can therefore best protect children now and in the future.
Help us fund vital medical research for children in the fight against COVID-19 with a donation today.
A history of protecting children
Action Medical Research has been protecting children for nearly 70 years, funding research to develop treatments, vaccinations and cures.
Since 1952, Action Medical Research has taken on polio, meningitis and rubella, and helped save countless lives. Today we continue to search for answers for some of the toughest fights our children face.